The project goal is to develop MS-CONNECT, a bioinformatics platform to support clinical decision making in neurology. MS-CONNECT allows the in-depth analysis of changes in neural ‘wiring’ in the brain (connectomics). It is based on Biomax’ existing NeuroXM platform, that offers secure patient data management and analysis (artificial intelligence) of brain data.